Procter and Gamble
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Procter and Gamble sits in the top decile of US sponsors by registered trial count (#306 of 15,742 sponsors by registered trial count).
Procter and Gamble: 70 sponsored US clinical trials, none currently recruiting.
Procter and Gamble sponsors 70 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 65 completed. 12 of these trials are in Phase 3-4 (later-stage) and 11 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Gingivitis, with 5 trials.
Top-decile sponsor footprint
Procter and Gamble ranks in the top decile of sponsors by registered trial count (#306 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
65 of 68 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (95.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
70 total, page 2 of 2
A Study is to Evaluate a Regimen on Gingivitis Using Traditional and Novel Assessment Methods
NCT07211061
Study to Evaluate a Probiotic in Healthy Subjects With a History of Abdominal Discomfort and Bloating
NCT01099696
Study to Evaluate the Effects of Psyllium on Blood Glucose
NCT00888602
Comparison of Prilosec Over-the-counter (OTC)® Versus Prevacid® for Gastric Acid Suppression
NCT00903448
A Controlled Clinical Study to Determine the Gingivitis Benefit of Flossing
NCT00855933
Study Evaluating the Pharmacokinetics of Doxylamine Succinate in Children
NCT00796315
Comparison of Prilosec OTC® Versus Zegerid® for Gastric Acid Suppression
NCT00808769
Evaluate Retention of an Orally Administered Device Using Gamma Scintigraphy Study 2
NCT00780286
Evaluate Retention of an Orally Administered Device Using Gamma Scintigraphy
NCT00754091
A Study of the Effects of Probiotics in Children Grades 1-3
NCT00635388
A Dose-Ranging Study of ATI 7505 in Patients With Postprandial Distress Syndrome
NCT00630370
Phase II, Randomized, Placebo-Controlled Study of ATI-7505 in Patients With Chronic Idiopathic Constipation
NCT00501241
Evaluation of 2 Oral Doses of PG-760564 in Rheumatoid Arthritis (RA) Patients Receiving Methotrexate
NCT00369928
Study to Evaluate Potential Food Effects
NCT00791817
Multiple Rising Oral Dose Study of PG 760564 Administered Twice Daily to Healthy Male/Female Volunteers for 14 Days
NCT00791388
Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI)
NCT00091637
Study of Oral PG-116800 Following a Heart Attack
NCT00067236
A Study to Assess the Ingestion of Dentifrice by Children
NCT02409836
Study of Metamucil on Blood Glucose and HbA1c in Type II NIDDM Subjects
NCT01582282
The Safety and Effectiveness of Peridex in Preventing or Delaying Fungal Infections of the Mouth in HIV-Infected Patients
NCT00002431
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 7 |
| Phase 2 | 4 |
| Phase 3 | 3 |
| Phase 4 | 9 |
Therapeutic Areas
How the Procter and Gamble archive is shaped
70 indexed studies, none listed as recruiting (0% open); 65 completed (93%).
Phase mix: 12 late (III/IV) vs 11 early (I/II) (balanced across stages).
Top condition: Gingivitis (5 trials), 9 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Procter and Gamble: archived-pipeline peers nationwide
Peers matched on 70 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Procter and Gamble sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 70 archived trials
- CSL Behring · 71 trials · 17% recruiting
- EMD Serono · 71 trials · 0% recruiting
- Nova Southeastern University · 71 trials · 21% recruiting
- Mallinckrodt · 69 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Procter and Gamble page
70 registered trials is a research-attention snapshot, not an endorsement of Procter and Gamble or any single study.
- None of Procter and Gamble's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Gingivitis is the condition Procter and Gamble studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Gingivitis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Procter and Gamble pipeline card: 70 registered trials from official public datasets.Report a data error.